Asthma and Respiratory Disorders News

Sputum neutrophil percentage and levels of eotaxin-1, IL-5 and eosinophil peroxidase may be used to predict remission among patients with severe asthma 1 year after anti-IL-5 therapy, according to a study published in CHEST.

ANAHEIM, Calif. — Common allergies and immunological conditions may be underdiagnosed by as much as half among patients who face language barriers, according to a poster presentation.

ANAHEIM, Calif. — Virtual coaching improved symptoms among patients who identified as Black with very poorly controlled asthma, according to a poster at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

HONOLULU — Patients with well-controlled asthma who use dupilumab may tolerate a reduction in the frequency of their doses from every 2 weeks to every 4 weeks, according to a poster presented at the CHEST Annual Meeting.

Incidence rates for several respiratory viruses, including influenza and respiratory syncytial virus, declined during vs. before the COVID-19 pandemic, according to study results published in Thorax.

ANAHEIM, Calif. — Allergists can screen patients for obstructive sleep apnea, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

ANAHEIM, Calif. — Patients with asthma can remediate mold damage in their homes after flooding caused by natural disasters, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

ANAHEIM, Calif. — Allergists can help adolescents and young adults with atopic conditions enlist in the military, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

ANAHEIM, Calif. — Physicians should have open conversations with their teenage patients with atopic conditions about how to safely navigate college environments, Ruchi S. Gupta, MD, MPH, said during this Healio exclusive interview.

Intranasal corticosteroids did not impact COVID-19 mortality in patients with asthma, COPD or neither, but they did reduce the risk for all-cause mortality, according to study results published in Annals of Allergy, Asthma & Immunology.